en
svPress releases
Press release 2023-04-26
Xspray Pharma receives expected partial decision in patent case regarding matter of law
Regulatory press release 2023-04-13
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2023-03-29
Xspray Pharma publishes its Annual Report 2022
Press release 2023-03-13
Board member in Xspray Pharma acquires shares from the CEO
Regulatory press release 2023-02-23
Xspray Pharma Partners with EVERSANA for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)
Regulatory press release 2023-02-15
Interim Report Fourth Quarter 2022
Press release 2022-12-13
Xspray presents novel scientific data for XS004 in the Chronic Myeloid Leukemia (CML) session at the 2022 Meeting of the American Society of Hematology
Press release 2022-11-30
Xspray Pharma’s drug candidate XS004 granted orphan drug designation in the US for the treatment of acute lymphoblastic leukemia
Regulatory press release 2022-11-09
Interim Report Third Quarter 2022
Press release 2022-11-03